Here's Why You Should Buy Acrivon Therapeutics (ACRV) Stock

Published on 28 May 2024 on Zacks via Yahoo Finance

Here's Why You Should Buy Acrivon Therapeutics (ACRV) Stock

Acrivon Therapeutics ACRV is a precision oncology company that has seen significant progress across its proprietary Acrivon Predictive Precision Proteomics (AP3) platform in 2024.

Acrivon Therapeutics achieved statistically significant prospective validation of its AP3 patient selection approach via its ACR-368 OncoSignature assay. This assay demonstrated an ability to identify ovarian and endometrial patients sensitive to ACR-368 monotherapy.

Read the rest of the article

NASDAQ.BVS price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Encore Wire Corp Exits Highlight Chuck Royce's Latest Investment Moves

The stock traded at an average price of $8.83 during the quarter. First Bancshares Inc (NYSE:FBMS...

GuruFocus.com · via Yahoo Finance 6 Nov 2024

Earnings call: Bioventus reports robust Q3 growth, raises full-year guidance By...

During the third quarter of 2024, Bioventus , a global leader in orthobiologic solutions, reporte...

Investing.com 6 Nov 2024

S&P 500 Gains 1%; Vimeo Shares Spike Higher - Vimeo (NASDAQ:VMEO)

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 350 ...

Benzinga 5 Nov 2024

Tesla, Celanese among Tuesday's morning market cap stock movers By Investing.com

Tesla, Celanese among Tuesday's morning market cap stock movers

Investing.com 5 Nov 2024

Bioventus Inc (BVS) Q3 2024 Earnings Report Preview: What To Look For

Bioventus Inc (NASDAQ:BVS) is set to release its Q3 2024 earnings on Nov 5, 2024. The consensus...

GuruFocus.com · via Yahoo Finance 5 Nov 2024

Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody

Biogen BIIB announced that the European Commission (EC) has granted marketing approval to Qalsody...

Zacks via Yahoo Finance 31 May 2024

Here's Why You Should Buy Acrivon Therapeutics (ACRV) Stock

Acrivon Therapeutics ACRV is a precision oncology company that has seen significant progress acro...

Zacks via Yahoo Finance 28 May 2024

Here's Why You Should Retain Centene (CNC) Stock for Now

Centene Corporation CNC is currently aided by improved premium and service revenues, Medicaid...

Zacks · via Yahoo Finance 21 May 2024

Bioventus Inc. (NASDAQ:BVS) Q4 2023 Earnings Call Transcript

Bioventus Inc. (NASDAQ:BVS) Q4 2023 Earnings Call Transcript March 12, 2024 Bioventus Inc. isn’t ...

Insider Monkey via Yahoo Finance 13 Mar 2024

Bioventus (BVS) to Report Q3 Earnings: What's in the Cards?

Bioventus Inc.’s BVS surgical solutions business unit sales are expected to be in focus when the ...

Zacks via Yahoo Finance 25 Oct 2023

News

Here's Why You Should Buy Acrivon Therapeutics (ACRV) Stock

NASDAQ.BVS price evolution

Want to become a better investor?